Gedeon Richter Plc. announces Esmya® (ulipristal acetate) 5mg as a pre-operative treatment of moderate to severe symptoms of uterine fibroids
[caption id="attachment_676" align="alignright" width="450" caption="Esmya® (ulipristal acetate)"][/caption]Results of data published in the New England Journal of Medicine in February confirm...
Read More

